Design and construction of diverse mammalian prion strains

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 48, 2009, Pages 20417-20422

  Colby, David W ^a   Giles, Kurt ^a,b   Legname, Giuseppe ^a,b,c   Wille, Holger ^a,b   Baskakov, Ilia V ^a,d   DeArmond, Stephen J ^a,b   Prusiner, Stanley B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SISSA   (Italy)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Amyloid; Conformation; Neurodegeneration; Stability; Synthetic prions

Indexed keywords

AMYLOID; PRION PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; INCUBATION TIME; INOCULATION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PREDICTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN STABILITY;

AMYLOID; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MICE; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; TIME FACTORS;

MAMMALIAN PRION; MUS;

EID: 73949160065     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0910350106     Document Type: Article

References (54)

1. Bruce ME, Dickinson AG (1987) Biological evidence that the scrapie agent has an independent genome. J Gen Virol 68:79-89.
2. Hsiao KK, et al. (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587-1590.
3. Hsiao KK, et al. (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91:9126-9130.
4. Sc conformers induced by a synthetic peptide and several prion strains. J Virol 78:2088-2099.
5. Nazor KE, et al. (2005) Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J 24:2472-2480.
6. Kaneko K, et al. (2000) A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol 295:997-1007.
7. +] factor by in vitro-converted Sup35 protein. Science 289:595-599.
8. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ (2002) Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 99:7402-7407.
9. Brachmann A, Baxa U, Wickner RB (2005) Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 24:3082-3092.
10. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428:323-328.
11. King CY, Diaz-Avalos R (2004) Protein-only transmission of three yeast prion strains. Nature 428:319-323.
12. Legname G, et al. (2004) Synthetic mammalian prions. Science 305:673-676.
13. Jackson WS, et al. (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63:438-450.
14. Gajdusek DC (1977) Unconventional viruses and the origin and disappearance of kuru. Science 197:943-960.
15. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383.
16. Caughey B, Baron GS (2006) Prions and their partners in crime. Nature 443:803-810.
17. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930-936.
18. Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annual Review of Pathology 3:11-40.
19. Dickinson AG, MeikleVM(1969) A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet Res 13:213-225.
20. Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. Journal of Comparative Pathology 83:29-40.
21. Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859-7868.
22. Telling GC, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
23. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383:685-690.
24. Legname G, et al. (2005) Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 102:2168-2173.
25. Legname G, et al. (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103:19105-19110.
26. Rogers DR (1965) Screening for amyloid with the thioflavin-t fluorescent method.Am J Clin Pathol 44:59-61.
27. Carlson GA, et al. (1994) Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91:5690-5694.
28. Telling GC, et al. (1996) Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 10:1736-1750.
29. Westaway D, et al. (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76:117-129.
30. Colby DW, et al. (2007) Prion detection by an amyloid seeding assay. Proc Natl Acad Sci USA 104:20914-20919.
31. Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442:585-589.
32. DeArmond SJ, et al. (1997) Selective neuronal targeting in prion disease. Neuron 19:1337-1348.
33. Tuzi NL, et al. (2008) Host PrP glycosylation: A major factor determining the outcome of prion infection. PLoS Biol 6:e100.
34. Piro JR, et al. (2009) Prion protein glycosylation is not required for strain-specific neurotropism. J Virol 83:5321-5328.
35. Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE (2002) Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277:21140-21148.
36. Stahl N, et al. (1992) Cataloguing post-translational modifications of the scrapie prion protein by mass spectrometry. Prion Diseases of Humans and Animals, eds Prusiner SB, Collinge J, Powell J, Anderton B (Ellis Horwood, London), pp 361-379.
37. Dickinson AG, Bruce ME, Outram GW, Kimberlin RH (1984) Scrapie strain differences: The implications of stability and mutation. Proceedings of Workshop on Slow Transmissible Diseases, ed Tateishi J (Japanese Ministry of Health and Welfare, Tokyo), pp 105-118.
38. Kimberlin RH, Walker CA (1985) Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23:74-81.
39. Schutt CR, Bartz JC (2008) Prion interference with multiple prion isolates. Prion 2:61-63.
40. +]. Science 268:880-884.
41. Shorter J, Lindquist S (2004) Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304:1793-1797.
42. Chien P, Weissman JS, DePace AH (2004) Emerging principles of conformation-based prion inheritance. Annu Rev Biochem 73:617-656.
43. Telling GC, et al. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90.
44. Perrier V, et al. (2002) Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci USA 99:13079-13084.
45. Cohen FE, et al. (1994) Structural clues to prion replication. Science 264:530-531.
46. Meyer-Luehmann M, et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781-1784.
47. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506.
48. Li JY, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14:501-503.
49. Prusiner SB, Cochran SP, Downey DE, Groth DF (1981) Determination of scrapie agent titer from incubation period measurements in hamsters. Hamster Immune Responses in Infectious and Oncologic Diseases, eds Streilein JW, Hart DA, Stein-Streilein J, Duncan WR, Billingham RE (Plenum Press, New York), pp 385-399.
50. Kimberlin RH, Walker CA (1978) Pathogenesis of mouse scrapie: Effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol 88:39-47.
51. Westaway D, et al. (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51:651-662.
52. Tamgüney G, et al. (2006) Transmission of elk and deer prions to transgenic mice. J Virol 80:9104-9114.
53. Mehlhorn I, et al. (1996) High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35:5528-5537.
54. Safar JG, et al. (2002) Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20:1147-1150.